Particle Sciences Inc. (PSI) and Celanese EVA Performance Polymers, a supplier of ethylene vinyl acetate (EVA) into pharmaceutical applications, are collaborating to provide PSI with preferred access to VitalDose™ EVA polymers for early-stage projects. Andrew Loxley, PSI’s director of New Technologies, remarked, “With combination products — devices that deliver drugs — there are multiple parties involved including the innovator, the API supplier, the development group and the poly...